Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CBLB | Q13191 | 20/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22528114 | 1.00 | CBLB (0.48) | CBLB | |
| SCHEMBL22528126 | 0.88 | CBLB (0.49) | CBLB | |
| SCHEMBL25411484 | 0.87 | CBLB (0.41) | CBLB | |
| SCHEMBL25413727 | 0.87 | CBLB (0.42) | CBLB | |
| SCHEMBL29089770 | 0.86 | CBLB (0.42) | CBLB | |
| SCHEMBL25411755 | 0.86 | CBLB (0.42) | CBLB | |
| SCHEMBL22527918 | 0.85 | CBLB (0.48) | CBLB | |
| SCHEMBL31314809 | 0.85 | CBLB (0.48) | CBLB | |
| SCHEMBL25414569 | 0.81 | CBLB (0.43) | CBLB | |
| SCHEMBL22527927 | 0.81 | CBLB (0.46) | CBLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4490152-A1 | ACTIVATORS OF EFFECTOR T CELLS | Orum Therapeutics Inc. (KR) | 2025-01-15 | — | — | EP | disclosed |
| CN-114364667-B | 3-Substituted piperidines for Cbl-b inhibition and use of Cbl-b inhibitors in combination with cancer vaccines and/or oncolytic viruses | 紐力克斯治疗公司 | 2025-01-10 | — | — | CN | disclosed |
| WO-2023170608-A1 | ACTIVATORS OF EFFECTOR T CELLS | ORUM THERAPEUTICS, INC. (KR) | 2023-09-14 | — | — | WO | disclosed |
| CN-114364667-A | 3-substituted piperidines for Cbl-b inhibition and the use of Cbl-b inhibitors in combination with cancer vaccines and/or oncolytic viruses | 紐力克斯治疗公司 | 2022-04-15 | — | — | CN | disclosed |